Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835224 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of L-NAME and Midodrine to Increase MAP
A Phase 2 study of Spinal Cord Injury and Orthostatic Hypotension, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT00835224: Completed Phase 2 study of Spinal Cord Injury and Orthostatic Hypotension, sponsored by US Department of Veterans Affairs.
NCT00835224 is a Phase 2 study of Spinal Cord Injury and Orthostatic Hypotension that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 34 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00835224, a Phase 2 study of Spinal Cord Injury and Orthostatic Hypotension, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
After a spinal cord injury the brain is no longer completely in control of the body below the level of injury. This affects many organs and systems in the body, we are interested in understanding how a spinal cord injury affects blood pressure and blood flow to the brain. We are going to study blood pressure while the person is seated in a wheelchair before and after we give the subject medications which should increase blood pressure in a laboratory setting and over the course of a normal day in persons with spinal cord injury.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Midodrine
- DRUG L-NAME
Study Locations (1)
New York
- VA Medical Center, Bronx - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-08 |
| Phase | Phase 2 |
What the finished NCT00835224 record still lists
NCT00835224 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower).
The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00835224 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00835224 about?
NCT00835224 is a clinical study titled "Safety and Efficacy of L-NAME and Midodrine to Increase MAP". After a spinal cord injury the brain is no longer completely in control of the body below the level of injury. This affects many organs and systems in the body, we are interested in understanding how a spinal cord injury affects blood pressure and blood flow to the brain. We are going to study blood...
What is the current status of trial NCT00835224?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2010-05. Estimated completion is 2013-08.
What conditions does trial NCT00835224 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Orthostatic Hypotension.
What interventions are being tested in trial NCT00835224?
The interventions under investigation include: Placebo (DRUG), Midodrine (DRUG), L-NAME (DRUG).
Who is sponsoring clinical trial NCT00835224?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00835224 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00835224's enrollment target sits among peer trials
34 43rd of 99 higher than 56 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury
RECRUITING · Phase 2
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
RECRUITING · Phase 2
-
Electrical Control of Bladder in Spinal Cord Injury Patients
COMPLETED · Phase 2
-
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
COMPLETED · Phase 2
-
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia